FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4214595120> ?p ?o ?g. }

• W4214595120 endingPage "499" @default.
• W4214595120 startingPage "495" @default.
• W4214595120 abstract "Definitive chemoradiotherapy (dCRT) is widely considered as a treatment option for cervical esophageal squamous cell carcinoma (ESCC) toward preserving the larynx. We have reported favorable outcomes, including the treatment response rate and short-term survival of dCRT concomitant with docetaxel, cisplatin, and 5-fluorouracil (DCF-RT) for advanced cervical ESCC. The aim of this paper was to report the subsequent progress of the study.We assessed 18 patients with advanced (clinical stage II-IV, including T4b and/or M1 lymph node) cervical ESCC at our department who received DCF-RT as the first-line treatment between December 2010 and June 2020.A total of 14 men and 4 women underwent the study regimen. The pretreatment clinical stage included stage II, stage III, stage IVA, and stage IVB cases (including 9 patients with T4b) [8 trachea and 2 thyroids] and 7 patients with the M1 lymph node. The complete response (CR) was achieved in 15 patients, stable disease in 2, and progressive disease in 1. Of 15 patients with CR, 7 experienced recurrence, and 8 had continued CR. Frequent cases of grade ≥3 adverse effects included leucopenia, neutropenia, febrile neutropenia, and pharyngeal pain. The 3-year overall survival rate, disease-free survival rate, and disease-specific survival rate were 44.2%, 47.7%, and 48.6%, respectively.DCF-RT for advanced cervical esophageal cancer could achieve a favorable prognosis with larynx preservation. Further observations are warranted to establish the long-term prognosis, late complications of radiotherapy, and the significance of salvage surgery." @default.
• W4214595120 created "2022-03-02" @default.
• W4214595120 creator A5002424722 @default.
• W4214595120 creator A5020864858 @default.
• W4214595120 creator A5029249568 @default.
• W4214595120 creator A5034655372 @default.
• W4214595120 creator A5049588335 @default.
• W4214595120 creator A5057059651 @default.
• W4214595120 creator A5058631036 @default.
• W4214595120 creator A5060027907 @default.
• W4214595120 creator A5086139902 @default.
• W4214595120 creator A5086895138 @default.
• W4214595120 creator A5087991866 @default.
• W4214595120 creator A5090003004 @default.
• W4214595120 date "2022-02-01" @default.
• W4214595120 modified "2023-09-30" @default.
• W4214595120 title "Definitive Chemoradiotherapy with Docetaxel, Cisplatin, and 5-Fluorouracil for Advanced Cervical Esophageal Cancer: A Medium-Term Outcome" @default.
• W4214595120 cites W1908082413 @default.
• W4214595120 cites W1957194715 @default.
• W4214595120 cites W2082824284 @default.
• W4214595120 cites W2124154051 @default.
• W4214595120 cites W2137749028 @default.
• W4214595120 cites W2139962184 @default.
• W4214595120 cites W2517104933 @default.
• W4214595120 cites W2542973470 @default.
• W4214595120 cites W2589524458 @default.
• W4214595120 cites W2757609263 @default.
• W4214595120 cites W2780006105 @default.
• W4214595120 cites W2782947136 @default.
• W4214595120 cites W2807844487 @default.
• W4214595120 cites W2914859390 @default.
• W4214595120 cites W3092008673 @default.
• W4214595120 cites W3148759746 @default.
• W4214595120 cites W2529056598 @default.
• W4214595120 doi "https://doi.org/10.31557/apjcp.2022.23.2.495" @default.
• W4214595120 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35225461" @default.
• W4214595120 hasPublicationYear "2022" @default.
• W4214595120 type Work @default.
• W4214595120 citedByCount "0" @default.
• W4214595120 crossrefType "journal-article" @default.
• W4214595120 hasAuthorship W4214595120A5002424722 @default.
• W4214595120 hasAuthorship W4214595120A5020864858 @default.
• W4214595120 hasAuthorship W4214595120A5029249568 @default.
• W4214595120 hasAuthorship W4214595120A5034655372 @default.
• W4214595120 hasAuthorship W4214595120A5049588335 @default.
• W4214595120 hasAuthorship W4214595120A5057059651 @default.
• W4214595120 hasAuthorship W4214595120A5058631036 @default.
• W4214595120 hasAuthorship W4214595120A5060027907 @default.
• W4214595120 hasAuthorship W4214595120A5086139902 @default.
• W4214595120 hasAuthorship W4214595120A5086895138 @default.
• W4214595120 hasAuthorship W4214595120A5087991866 @default.
• W4214595120 hasAuthorship W4214595120A5090003004 @default.
• W4214595120 hasBestOaLocation W42145951201 @default.
• W4214595120 hasConcept C121608353 @default.
• W4214595120 hasConcept C126322002 @default.
• W4214595120 hasConcept C141071460 @default.
• W4214595120 hasConcept C143998085 @default.
• W4214595120 hasConcept C146357865 @default.
• W4214595120 hasConcept C151730666 @default.
• W4214595120 hasConcept C2776283816 @default.
• W4214595120 hasConcept C2776694085 @default.
• W4214595120 hasConcept C2777063308 @default.
• W4214595120 hasConcept C2778220009 @default.
• W4214595120 hasConcept C2778424827 @default.
• W4214595120 hasConcept C2778850193 @default.
• W4214595120 hasConcept C2779742542 @default.
• W4214595120 hasConcept C2780456651 @default.
• W4214595120 hasConcept C2781190966 @default.
• W4214595120 hasConcept C2781413609 @default.
• W4214595120 hasConcept C509974204 @default.
• W4214595120 hasConcept C71924100 @default.
• W4214595120 hasConcept C86803240 @default.
• W4214595120 hasConcept C90924648 @default.
• W4214595120 hasConceptScore W4214595120C121608353 @default.
• W4214595120 hasConceptScore W4214595120C126322002 @default.
• W4214595120 hasConceptScore W4214595120C141071460 @default.
• W4214595120 hasConceptScore W4214595120C143998085 @default.
• W4214595120 hasConceptScore W4214595120C146357865 @default.
• W4214595120 hasConceptScore W4214595120C151730666 @default.
• W4214595120 hasConceptScore W4214595120C2776283816 @default.
• W4214595120 hasConceptScore W4214595120C2776694085 @default.
• W4214595120 hasConceptScore W4214595120C2777063308 @default.
• W4214595120 hasConceptScore W4214595120C2778220009 @default.
• W4214595120 hasConceptScore W4214595120C2778424827 @default.
• W4214595120 hasConceptScore W4214595120C2778850193 @default.
• W4214595120 hasConceptScore W4214595120C2779742542 @default.
• W4214595120 hasConceptScore W4214595120C2780456651 @default.
• W4214595120 hasConceptScore W4214595120C2781190966 @default.
• W4214595120 hasConceptScore W4214595120C2781413609 @default.
• W4214595120 hasConceptScore W4214595120C509974204 @default.
• W4214595120 hasConceptScore W4214595120C71924100 @default.
• W4214595120 hasConceptScore W4214595120C86803240 @default.
• W4214595120 hasConceptScore W4214595120C90924648 @default.
• W4214595120 hasIssue "2" @default.
• W4214595120 hasLocation W42145951201 @default.
• W4214595120 hasLocation W42145951202 @default.
• W4214595120 hasLocation W42145951203 @default.
• W4214595120 hasOpenAccess W4214595120 @default.

• next